Pivotal-Point Monitoring CareDX (CDNA): Transplant Diagnostics Specialist Sees High Demand for Molecular Monitoring Tests
Reading Time: 1 minute
CareDX is a precision medicine company that specializes in diagnostic solutions for organ transplantation. With testing methods like AlloSure (kidney, heart, lung) and AlloMap, the company offers non-invasive monitoring methods for the early detection of rejection reactions. The crucial trigger for the leap in stock price on July 16 was the final reimbursement policy from the US health insurance Medicare. This ensured the broad coverage of testing costs permanently and eliminated regulatory uncertainties. As a result, testing volumes increased significantly,...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

